Product
Tranilast
2 clinical trials
5 indications
Indication
Nasopharyngeal CarcinomaIndication
Recurrent CancerIndication
NLRP3Indication
hs-CRPIndication
AngioplastyClinical trial
Application of Tranilast as a Radiosensitizer in the Treatment of Radiotherapy Resistant Nasopharyngeal Carcinoma: a Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2024-07-20
Clinical trial
Effect of Inflammasome Inhibitor on High-sensitivity C-reactive Protein in Patients After Percutaneous Coronary InterventionStatus: Completed, Estimated PCD: 2023-02-01